Metraipolis › archive › dc_62cac0241409
Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy — Europe PMC PMID:40860882
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40860882
- DOI
- 10.3389/fphar.2025.1643791
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T17:48:59.638Z
- SHA-256 of the archived text
89ad6e7bc3f11a75df8775f15f5b9e40c9cfb808508f6b5108db12dffdc24aba- Stable URL of this page
https://metraipolis.com/documento/dc_62cac0241409
How to cite
Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy — Europe PMC PMID:40860882 — Europe PMC (en), https://europepmc.org/article/MED/40860882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62cac0241409 (Metraipolis archive dc_62cac0241409, sha256 89ad6e7bc3f11a75df8775f15f5b9e40c9cfb808508f6b5108db12dffdc24aba)
BibTeX
@misc{dc62cac0241409,
title = {Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy — Europe PMC PMID:40860882},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40860882},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62cac0241409; sha256 89ad6e7bc3f11a75df8775f15f5b9e40c9cfb808508f6b5108db12dffdc24aba},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40860882. Agents can read the archived copy with the MCP tool read_document.